Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020

SELL
$15.4 - $20.16 $513,389 - $672,073
-33,337 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$18.24 - $21.45 $1.03 Million - $1.22 Million
-56,691 Reduced 62.97%
33,337 $608,000
Q1 2020

May 14, 2020

SELL
$16.28 - $25.63 $153,846 - $242,203
-9,450 Reduced 9.5%
90,028 $1.81 Million
Q4 2019

Feb 11, 2020

SELL
$19.57 - $23.52 $11,937 - $14,347
-610 Reduced 0.61%
99,478 $2.32 Million
Q3 2019

Nov 12, 2019

SELL
$19.85 - $22.76 $404,443 - $463,735
-20,375 Reduced 16.91%
100,088 $2.01 Million
Q2 2019

Aug 14, 2019

SELL
$17.59 - $21.1 $261,545 - $313,735
-14,869 Reduced 10.99%
120,463 $0
Q1 2019

May 15, 2019

BUY
$18.01 - $20.11 $62,080 - $69,319
3,447 Added 2.61%
135,332 $0
Q4 2018

Feb 15, 2019

SELL
$17.44 - $21.53 $119,324 - $147,308
-6,842 Reduced 4.93%
131,885 $2.42 Million
Q3 2018

Nov 14, 2018

SELL
$19.97 - $21.96 $144,063 - $158,419
-7,214 Reduced 4.94%
138,727 $0
Q2 2018

Aug 08, 2018

BUY
$20.16 - $24.68 $2.94 Million - $3.6 Million
145,941 New
145,941 $0

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.31B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Segall Bryant & Hamill, LLC Portfolio

Follow Segall Bryant & Hamill, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.